PhaBuilder Valuation, Funding & Investors

PhaBuilder is valued at $287M as of February 2023.

Last PhaBuilder valuation

$287M

Series A · Feb 2023

Last PhaBuilder funding round

$52M

Series A · Feb 2023

Cumulative funding PhaBuilder raised

$112M

across 4 funding rounds

Key investors in PhaBuilder

  • HSG
  • Z&H Investment
  • GRC SinoGreen Fund
  • Sino Biological
  • Shenzhen Guozhong Venture Capital Management
  • FTZ Fund

PhaBuilder Overview

About PhaBuilder

PhaBuilder is a synthetic biology firm engineering halophilic microbes for industrial applications through next-generation biotechnology. It produces biodegradable PHA polymers, ectoine as a pharmaceutical intermediate, and cadaverine for Nylon 56 precursors. Based in Beijing at the China-Germany Industrial Park, PhaBuilder develops products in its synthetic biology facility and constructs a PHA production plant in Yichang, Hubei Province. The company expands with additional large-scale bases across China.


Founded

2021

HQ

ChinaBeijing

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Valuation

$287M (Feb 2023)

PhaBuilder Valuation

PhaBuilder is currently valued at $287M, based on its Series A in February 2023. Read the announcement ↗

The $52M round was led by China National Petroleum Group Kunlun Capital, with participation from FTZ Fund, Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership), Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership), Enterprise Mixed Ownership Reform Fund, Lhasa Alec Investment Consulting and 6 other investors.

PhaBuilder valuation by funding round

PhaBuilder valuation by funding round
DateStageValuation
Feb 2023Series A$287M

PhaBuilder Funding History

PhaBuilder has raised a total of $112M across 4 funding rounds.

PhaBuilder's first fundraising round was a $8M angel round in July 2021. The most recent completed round was a $52M Series A in February 2023.

PhaBuilder funding rounds

PhaBuilder funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Feb 2023Series AChina National Petroleum Group Kunlun Capital (lead); FTZ Fund; Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership); Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership); Enterprise Mixed Ownership Reform Fund; Lhasa Alec Investment Consulting; Mingqu Capital; Sino Biological; GRC SinoGreen Fund; Agricultural Fund of China; Z&H Investment; HSG$52M$287M-
Nov 2022Series ASino Biological (lead)$13M--
Jan 2022Series AChengtong Mixed Reform (lead); Huakong Electronic Technology; Shenzhen Guozhong Venture Capital Management; Beijing Linkong Xingrong Investment; GRC SinoGreen Fund; Z&H Investment; HSG$39M--
Jul 2021AngelHSG (lead); SEE Fund; Ningbo Qiwu Management Consulting Partnership$8M-Beijing PhaBuilder Biotechnology Co., Ltd. develops synthetic biology technologies to produce PHA (Polyhydroxyalkanoates), a family of biodegradable polymers including PHB, PHBV, and P34HB, for applications in medical, fashion, 3D printing, packaging, and consumer goods. The company engineers halophilic microorganisms using non-grain carbon sources like straw and kitchen waste, integrating Industry 4.0 principles for high-efficiency, low-carbon biomanufacturing. PhaBuilder promotes a 'PHA Life' concept to create green, low-carbon lifestyles by replacing traditional plastics with biodegradable PHA products. Founded in 2021, it originated from Tsinghua University technology by Professor George Guo-Qiang Chen.

Who has invested in PhaBuilder?

18 investors have backed PhaBuilder across its funding rounds, including HSG, Z&H Investment, GRC SinoGreen Fund, Sino Biological, Shenzhen Guozhong Venture Capital Management and FTZ Fund.

Lead investors include China National Petroleum Group Kunlun Capital, Sino Biological, Chengtong Mixed Reform and HSG.


PhaBuilder Investors

Investors in PhaBuilder by funding rounds participated
InvestorHQRoundsRoleFirst check
HSGHong KongHong Kong3LeadJul 2021
Sino BiologicalChinaBeijing2LeadNov 2022
GRC SinoGreen FundChinaShenzhen2ParticipantJan 2022
Z&H InvestmentChinaBeijing2ParticipantJan 2022
Huakong Electronic TechnologyChinaTianjin1ParticipantJan 2022
FTZ FundChinaShanghai1ParticipantFeb 2023
Chengtong Mixed ReformChinaChina1LeadJan 2022
SEE FundChinaTianjin1ParticipantJul 2021
Shenzhen Guozhong Venture Capital ManagementChinaShenzhen1ParticipantJan 2022
Ningbo Qiwu Management Consulting PartnershipChinaChina1ParticipantJul 2021
Shanghai Lingang Life Blue Bay Phase I Private Investment Fund Partnership (Limited Partnership)ChinaShanghai1ParticipantFeb 2023
Shanghai Jisheng Jia No. 1 Private Investment Fund Partnership (Limited Partnership)ChinaShanghai1ParticipantFeb 2023
Enterprise Mixed Ownership Reform FundChinaShanghai1ParticipantFeb 2023

This data is available for Pro users. Sign up to see all 18 PhaBuilder investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

PhaBuilder Competitors

PhaBuilder competitors include listed companies like eVISO and Alfa Solar, and private ones like BioElements, Toraphene, TemperPack and Hydrosat.

Public and private companies comparable to PhaBuilder
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
BioElementsChileSantiagoPrivate$6M-$200M33.3x
TorapheneUnited KingdomLondonPrivate$1M-$111M110.5x
TemperPackUnited StatesRichmond, VAPrivate--$108M-
HydrosatUnited StatesWashington, DCPrivate--$180M-
eVISOItalyItalyPublicly listed$363M$12M$277M0.6x
Alfa SolarTurkeyTurkeyPublicly listed$169M$10M$256M-

PhaBuilder Public Comps

PhaBuilder is still privately-owned, but its public comps include eVISO, Transcontinental, Alfa Solar, Smart Gunes Enerjisi Tek, Nampak, Itafos, Tredegar, Clearwater Paper, Envipco Holding and Ranpak.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
eVISO$363M$12M0.7x0.6x22.8x16.6x
Transcontinental$2B$340M0.3x0.6x1.8x3.6x
Alfa Solar$169M$10M1.7x-30.6x-
Smart Gunes Enerjisi Tek$217M$49M2.3x-10.3x-
Nampak$660M$136M0.7x0.7x3.3x4.8x
Itafos$558M$189M0.7x0.6x1.9x3.4x
Tredegar$723M$56M0.4x-5.0x-
Clearwater Paper$1.6B$47M0.4x0.4x13.1x10.4x

This data is available for Pro users. Sign up to see all PhaBuilder competitors and their valuation data.

Start Free Trial

Common questions about PhaBuilder

When was PhaBuilder founded?PhaBuilder was founded in 2021.
Where is PhaBuilder headquartered?PhaBuilder is headquartered in Beijing, China.
Is PhaBuilder publicly listed?No, PhaBuilder is a private, VC-backed company.
What is PhaBuilder's valuation?PhaBuilder was last valued at $287M in its Series A in February 2023.
How much funding has PhaBuilder raised?PhaBuilder has raised $112M across 4 funding rounds.
What was PhaBuilder's last funding round?PhaBuilder's last funding round was a $52M Series A in February 2023, led by China National Petroleum Group Kunlun Capital.
Who are PhaBuilder's investors?PhaBuilder's investors include HSG, Sino Biological, GRC SinoGreen Fund, Z&H Investment, Huakong Electronic Technology, FTZ Fund, Chengtong Mixed Reform, SEE Fund, Shenzhen Guozhong Venture Capital Management, Ningbo Qiwu Management Consulting Partnership and 8 others.
Which companies are comparable to PhaBuilder?Companies comparable to PhaBuilder include BioElements, Toraphene, TemperPack, Hydrosat, eVISO and Alfa Solar.

See companies similar to PhaBuilder

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial